靶向细胞凋亡的海洋抗肿瘤多肽药物研究进展

doi:10.3976/j.issn.1002-4026.2015.03.004

摘要/Abstract

摘要： 凋亡在肿瘤的形成和发展中具有重要功能，靶向凋亡通路已成为发展化疗药物的重要策略。海洋生物多肽是抗肿瘤药物的重要来源，并且已经发现的大多数抗肿瘤海洋多肽都可以通过诱导凋亡途径发挥抗肿瘤作用。本文针对这类海洋药物研发中存在的药物抗原性及药物来源等主要问题，综述了近年来发现的海洋多肽及其诱导细胞凋亡的信号通路。

关键词: 海洋多肽, 抗肿瘤, 细胞凋亡

Abstract: Apoptosis plays an important role in formation and development of a cancer. Targeting apoptotic pathway has become a significant strategy for developing chemotherapeutic agents. Marine peptides is an important source for antitumor drugs, most of which can exert antitumor effect by inducing apoptotic pathway. We survey recently discovered marine peptides and apoptotic signal pathway for drug antigenicity and drug sources in the development for such marine drugs.

Key words: apoptosis, marine peptide, antitumor

中图分类号:

林秀坤，苏硕楠. 靶向细胞凋亡的海洋抗肿瘤多肽药物研究进展[J]. 山东科学, 2015, 28(3): 16-22.

LIN Xiukun,SU Shuonan. Research advances of marine antitumor peptides targeting apoptosis[J]. SHANDONG SCIENCE, 2015, 28(3): 16-22.

参考文献

［1］REED J C. Mechanisms of apoptosis［J］. Am J Pathol, 2000, 157(5):1415-1430. ［2］ BURZ C, BERINDANNEAGOE I, BALACESCU O, et al.Apoptosis in cancer:Key molecular signaling pathways and therapy targets［J］.Acta Oncol,2009,48 (6): 811-821. ［3］ GHOBRIAL I M, WITZIG T E, ADJEI A A. Targeting apoptosis pathways in cancer therapy［J］. CA Cancer J Clin，2005,55 (3):178-194. ［4］ ABE K, KURAKIN A, MOHSENIMAYBODI M, et al. The complexity of TNFrelated apoptosisinducing ligand［J］. Ann N Y Acad Sci, 2000, (926): 52-63. ［5］ OZOREN N, ELDEIRY W S. Cell surface death receptor signaling in normal and cancer cells［J］. Semin Cancer Biol, 2003,13 (2):135-147. ［6］ PETER M E, KRAMMER P H.The CD95(APO1/Fas) DISC and beyond［J］.Cell Death Differ, 2003,10 (1):26-35. ［7］ THORBURN A. Death receptorinduced cell killing［J］.Cell Signal,2004,16 (2):139-144. ［8］KROEMER G. Mitochondrial control of apoptosis: an introduction［J］. Biochem Biophys Res Commun, 2003,304 (3):433-435. ［9］ GUPTA S, KASS G E, SZEGEZDI E, et al. The mitochondrial death pathway:A promising therapeutic target in diseases［J］. J Cell Mol Med, 2009,13 (6): 1004-1033. ［10］ LIN X K, LIU M, HU C X, et al. Targeting cellular proapoptotic molecules for developing anticancer agents from marine sources［J］.Curr Drug Targets, 2010,11 (6):708-715. ［11］ZHENG L H, WANG Y J, SHENG J, et al. Antitumor peptides from marine organisms［J］.Mar Drugs, 2011,9 (10):1840-1859. ［12］ YIP KW, REED J C. Bcl2 family proteins and cancer［J］.Oncogene， 2008，27 (50) ： 6398-6406. ［13］ OKUN I, BALAKIN K V, TKACHENKO S E, et al. Caspase activity modulators as anticancer agents［J］.Anticancer Agents Med Chem,2008,8 (3): 322-341. ［14］MARTELLI A M, TAZZARI P L, EVANGELISTI C, et al.Targeting the phosphatidylinositol 3kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside［J］. Curr Med Chem， 2007,14 (19):2009-2023. ［15］ KANG M H, REYNOLDS C P.Bcl2 inhibitors: Targeting mitochondrial apoptotic pathways in cancer therapy［J］.Clin Cancer Res， 2009,15 (4): 1126-1132. ［16］ WONG W W, PUTHALAKATH H. Bcl2 family proteins: the sentinels of the mitochondrial apoptosis pathway［J］.IUBMB Life,2008,60 (6):390-397. ［17］ BRAEKMAN J C, DALOZE D, MOUSSIAUX B, et al.Jaspamide from the marine sponge Jaspis johnstoni［J］.J Nat Prod, 1987,50 (5):994-995. ［18］ WATTS K R, MORINAKA B I, AMAGATA T, et al. Biostructural features of additional jasplakinolide (jaspamide) analogues［J］. J Nat Prod, 2011,74 (3): 341-351. ［19］ BAI R, PETTIT G R, HAMEL E. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain［J］.Biochem Pharmacol, 1990,39 (12):1941-1949. ［20］ MAKI A, DIWAKARAN H, REDMAN B, et al. The Bcl2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma［J］.Anticancer Drugs,1995,6 (3):392-397. ［21］ van de DONK N W C J, DHIMOLEA E. Brentuximab vedotin［J］. MAbs,2012,4 (4):458-465. ［22］ MINICH S S. Brentuximab vedotin:A new age in the treatment of Hodgkin lymphoma and anaplastic large cell lymphoma［J］. Ann Pharmacother, 2012,46 (3):377-383. ［23］ HUANG T C, LEE J F, CHEN J Y. Pardaxin, an antimicrobial peptide, triggers caspasedependent and ROSmediated apoptosis in HT1080 cells［J］. Mar Drugs, 2011,9(10):1995-2009. ［24］ NOGLE L M, GERWICK W H. Somocystinamide A, a novel cytotoxic disulfide dimer from a Fijian marine cyanobacterial mixed assemblage［J］.Org Lett,2002,4 (7):1095-1098. ［25］ WRASIDLO W, MIELGO A, TORRES V A, et al. The marine lipopeptide somocystinamide A triggers apoptosisviacaspase 8［J］.Proc Natl Acad Sci U SA， 2008,105 (7):2313-2318. ［26］ SCHIRMER T, HUBER R, SCHNEIDER M, et al. Crystal structure analysis and refinement at 2.5 A of hexameric Cphycocyanin from the cyanobacterium Agmenellum quadruplicatum.The molecular model and its implications for lightharvesting［J］.J Mol Biol,1986,188 (4):651-676. ［27］ LI B, GAO M H, ZHANG X C, et al. Molecular immune mechanism of Cphycocyanin from Spirulina platensisinduces apoptosis in HeLa cells in vitro［J］.Biotechnol Appl Biochem,2006,43 (3):155-164. ［28］ SCORRANO L. Opening the doors to cytochrome C: Changes in mitochondrial shape and apoptosis［J］. Int J Biochem Cell Biol, 2009,41 (10):1875-1883. ［29］ CHENG L Y, WANG C G, LIU H Z, et al.A novel polypeptide extracted fromCiona savignyi induces apoptosis through a mitochondrialmediated pathway in human colorectal carcinoma cells［J］. Clin Colorectal Cancer, 2012,11 (3): 207-214. ［30］ WANG C C, LIU M, CHENG L Y, et al. A novel polypeptide from Meretrix meretrix Linnaeus inhibits the growth of human lung adenocarcinoma［J］. Exp Biol Med, 2012,237 (4):442-450. ［31］ DHANASEKARAN D N, REDDY E P. JNK signaling in apoptosis［J］. Oncogene, 2008,27 (48):6245-6251. ［32］ DEPENBROCK H, PETER R, FAIRCLOTH G T, et al.In vitro activity of aplidine, a new marinederived anticancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells［J］.Br J Cancer, 1998,78 (6):739-744. ［33］ URDIALES J L, MORATA P, NUNEZ de CASTRO I, et al.Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates［J］.Cancer Lett, 1996,102 (1/2):31-37. ［34］ RINEHART K L. Antitumor compounds from tunicates［J］. Med Res Rev, 2000, 20 (1):1-27. ［35］ FAIVRE S, CHIZE S, DELBALDO C, et al. Phase I and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignancies［J］.J Clin Oncol, 2005,23 (31):7871-7880. ［36］ MAROUN J A, BELANGER K, SEYMOUR L, et al.Phase I study of Aplidine in a daily × 5 onehour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115［J］.Ann Oncol, 2006,17 (9):1371-1378. ［37］ NALDAMOLINA R, VALENZUELA B, RAMONLOPEZ A, et al. Population pharmacokinetics metaanalysis of plitidepsin (Aplidin) in cancer subjects［J］.Cancer Chemother Pharmacol, 2009,64(1):97-108. ［38］BRUGGE J, HUNG M C, MILLS G B. A new mutational Aktivation in the PI3K pathway［J］. Cancer Cell , 2007,12 (2):104-107. ［39］ YU L, WANG L T, CHEN S W. Dual character of Tolllike receptor signaling: Protumorigenic effects and antitumor functions［J］. Biochim Biophys Acta, 2013, 1835 (2):144-154. ［40］ HAMANN M T, OTTO C S, SCHEUER P J, et al. Kahalalides: Bioactive peptides from a marine mollusk Elysia rufescens and its algal diet Bryopsis sp.(1)［J］. J Org Chem, 1996,61 (19): 6594-6600. ［41］ JANMAAT M L, RODRIGUEZ J A, JIMENO J, et al.Kahalalide F induces necrosislike cell death that involves depletion of ErbB3 and inhibition of Akt signaling［J］. Mol Pharmacol, 2005,68 (2):502-510. ［42］ LING Y H, ARACIL M, ZOU Y, et al.PM02734 (elisidepsin) induces caspaseindependent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of deathassociated protein kinase［J］.Clin Cancer Res, 2011, 17 (16):5353-5366. ［43］ LING Y H, ARACIL M, JIMENO J, et al.Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib;synergistic activity in human nonsmall cell lung cancer cell lines and xenograft models［J］.Eur J Cancer, 2009,45 (10):1855-1864. ［44］ TEIXIDO C, ARGUELAGUET E, PONS B, et al.ErbB3 expression predicts sensitivity to elisidepsin treatment:in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung,breast and colon cancer cell lines［J］. Int J Oncol, 2012,41 (1): 317-324. ［45］ GARCIAFERNANDEZ L F, LOSADA A, V ALCAIDE, et al.Aplidin induces the mitochondrial apoptotic pathwayviaoxidative stressmediated JNK and p38 activation and protein kinase C delta［J］. Oncogene, 2002,21 (49):7533-7544. ［46］ CIOCA D P, KITANO K. Induction of apoptosis and CD10/neutral endopeptidase expression by jaspamide in HL60 line cells［J］. Cell Mol Life Sci， 2002,59 (8):1377-1387. ［47］ SATO M, SAGAWA M, NAKAZATO T, et al.A natural peptide, dolastatin 15, induces G2/M cell cycle arrest and apoptosis of human multiple myeloma cells［J］. Int J Oncol,2007,30 (6):1453-1459. ［48］ RINEHART K L,GLOER J B,HUGHES R G, et al. Didemnins: Antiviral and antitumor depsipeptides from a Caribbean tunicate［J］. Science, 1981,212 (4497):933-935. ［49］ CHUN H G, DAVIES B, HOTH D, et al. Didemnin B［J］. Invest New Drug, 1986,4 (3):279-284. ［50］ RINEHART K L, HOLT T G, FREGEAU N L, et al. Bioactive compounds from aquatic and terrestrial sources［J］. J Nat Prod, 1990,53 (4):771-792. ［51］ PAN P S, VASKO R C, LAPERA S A, et al.A comprehensive study of Sansalvamide A derivatives: the structure–activity relationships of 78 derivatives in two pancreatic cancer cell lines［J］ Bioorg Med Chem, 2009,17 (16):5806-5825. ［52］ HWANG Y, ROWLEY D, RHODES D, et al. Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide A［J］.Mol Pharmacol, 1999,55 (6):1049-1053. ［53］HAMBLEY T W, HAWKINS C J, MF LAVIN, et al. Cycloxazoline:A cytotoxic cyclic hexapeptide from the ascidianLissoclinum bistratum［J］. Tetrahedron, 1992,48:341-348. ［54］WATTERS D J, BEAMISH H J, MARSHALL K A, et al.Accumulation of HL60 leukemia cells in G2/M and inhibition of cytokinesis caused by two marine compounds, bistratene A and cycloxazoline［J］.Cancer Chemother Pharmacol, 1994,33 (5):399-409. ［55］CARROLL A R, FENG Y, BOWDEN B F, et al. Studies of Australian ascidians. 5.Virenamides A–C, new cytotoxic linear peptides from the colonial didemnid ascidian Diplosoma virens［J］.J Org Chem, 1996,61 (12):4059-4061.

[1]	曹铭晨,彭小菊,黄先菊,柯才华,汪川,辛兆洋,于振英,潘冬琦,崔萌纳. 基于网络药理学的扶正调理液作用机制及其对S180荷瘤小鼠的影响[J]. 山东科学, 2022, 35(1): 45-55.
[2]	董祺，高志惠. 蛹虫草子实体胶囊对S180小鼠抗肿瘤作用的实验研究[J]. 山东科学, 2016, 29(2): 25-29.
[3]	王萍, 张少华. 中药夏枯草抗肿瘤机制研究概况[J]. J4, 2010, 23(2): 38-41.